MyFinsight
Home
Blog
About
Contact
Download
Download image
Of which net loss
attributable to controlling...
-$227,318K
Net loss
-$230,321K
Loss before income
tax
-$229,710K
Income tax expense
$611K
Other income, net
$22,372K
Operating loss
-$244,834K
Interest expense
$7,248K
Total operating
expenses
$244,834K
Research and development
$202,862K
General and
administrative
$41,972K
Back
Back
Income Statement
source: myfinsight.com
MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics (MLTX)